Plain-English translation of NCT05928429 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether wearing special glycerine-filled frozen gloves and socks during paclitaxel chemotherapy can prevent a common side effect called peripheral neuropathy—a condition where patients experience numbness, tingling, and nerve pain in their hands and feet. About half of participants will wear the frozen gloves and socks during their chemotherapy infusions, while the other half will receive chemotherapy without this intervention. The study will measure how many people develop nerve damage and how severe it is.
Paclitaxel is an effective chemotherapy drug for breast cancer, but it frequently causes nerve damage that can be painful and long-lasting. Currently, there is no proven way to prevent this side effect, so researchers are testing whether keeping hands and feet cold during treatment might reduce the risk of nerve damage.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either wear frozen gloves and socks or receive standard chemotherapy without them. If you are in the frozen glove group, you will put on the special glycerine-filled gloves and socks about 15 minutes before each chemotherapy infusion and keep them on for about 90 minutes total (15 minutes before, during the 1-hour infusion, and 15 minutes after). You will have nerve function tests performed about 3 weeks after your last chemotherapy dose to see if you developed nerve damage.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Denmark